These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22617423)

  • 21. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
    Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene.
    Hwang ES; Riese DJ; Settleman J; Nilson LA; Honig J; Flynn S; DiMaio D
    J Virol; 1993 Jul; 67(7):3720-9. PubMed ID: 8389903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV-16 RNA processing.
    Schwartz S
    Front Biosci; 2008 May; 13():5880-91. PubMed ID: 18508629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers.
    Zhao X; Fay J; Lambkin H; Schwartz S
    Virology; 2007 Dec; 369(2):351-63. PubMed ID: 17869320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms and functional analysis of the intact human papillomavirus16 e2 gene.
    Ekalaksananan T; Jungpol W; Prasitthimay C; Wongjampa W; Kongyingyoes B; Pientong C
    Asian Pac J Cancer Prev; 2014; 15(23):10255-62. PubMed ID: 25556457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific interaction between hnRNP H and HPV16 L1 proteins: implications for late gene auto-regulation enabling rapid viral capsid protein production.
    Zheng ZZ; Sun YY; Zhao M; Huang H; Zhang J; Xia NS; Miao J; Zhao Q
    Biochem Biophys Res Commun; 2013 Jan; 430(3):1047-53. PubMed ID: 23261416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
    Hubert WG; Laimins LA
    J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral interaction: a possible contributing factor in head and neck cancer progression.
    Underbrink MP; Hoskins SL; Pou AM; Albrecht T
    Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Deacetylase SIRT1 Regulates the Replication Properties of Human Papillomavirus 16 E1 and E2.
    Das D; Smith N; Wang X; Morgan IM
    J Virol; 2017 May; 91(10):. PubMed ID: 28275188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.
    Magaldi TG; Almstead LL; Bellone S; Prevatt EG; Santin AD; DiMaio D
    Virology; 2012 Jan; 422(1):114-24. PubMed ID: 22056390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of cellular proliferation by the papillomavirus E2 protein.
    Dowhanick JJ; McBride AA; Howley PM
    J Virol; 1995 Dec; 69(12):7791-9. PubMed ID: 7494290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation.
    Graham SV
    Viruses; 2017 Aug; 9(9):. PubMed ID: 28867768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.
    Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S
    J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV 16 E2 protein induces apoptosis in human and murine HPV 16 transformed epithelial cells and has antitumoral effects in vivo.
    Bermúdez-Morales VH; Peralta-Zaragoza O; Guzmán-Olea E; García-Carrancá A; Bahena-Román M; Alcocer-González JM; Madrid-Marina V
    Tumour Biol; 2009; 30(2):61-72. PubMed ID: 19390235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of human papillomavirus 16 physical status through E1/E6 and E2/E6 ratio analysis.
    Tsakogiannis D; Kyriakopoulou Z; Ruether IGA; Amoutzias GD; Dimitriou TG; Diamantidou V; Kotsovassilis C; Markoulatos P
    J Med Microbiol; 2014 Dec; 63(Pt 12):1716-1723. PubMed ID: 25212758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2.
    Gammoh N; Isaacson E; Tomaić V; Jackson DJ; Doorbar J; Banks L
    Oncogene; 2009 Jun; 28(23):2299-304. PubMed ID: 19421149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle.
    Terhune SS; Milcarek C; Laimins LA
    J Virol; 1999 Sep; 73(9):7185-92. PubMed ID: 10438805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.